FDA Inspection 1217569 — Hetero Labs Limited

Hetero Labs Limited — FEI 3004378446

The FDA completed an inspection of Hetero Labs Limited on September 8, 2023 in Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 8, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)